小隐寺数据中心API 小隐寺主站

Affinity Asset Advisors, LLC 13F 持仓明细(2026-03-31) · 小隐寺数据中心

Affinity Asset Advisors, LLC

报告期 2026-03-31 · CIK 0001773195

持仓数

105

前50大市值合计

$1.70B

报告期

2026-03-31

当前持仓调仓

前 50 大持仓

标的

类型

市值

股数

占比*

SPY STATE STR SPDR S&P 500 ETF T

TR UNIT · 认沽

$130.1M

200,000

7.7%

APGE APOGEE THERAPEUTICS INC

COM

$108.2M

1,284,926

6.4%

XENE XENON PHARMACEUTICALS INC

COM

$97.4M

1,675,000

5.7%

ERAS ERASCA INC

COM

$86.6M

5,350,000

5.1%

INSM INSMED INC

COM PAR $.01

$78.5M

480,000

4.6%

— ROIVANT SCIENCES LTD

SHS

$77.6M

2,800,000

4.6%

SYRE SPYRE THERAPEUTICS INC

COM NEW

$64.5M

1,279,134

3.8%

— CENTESSA PHARMACEUTICALS PLC

SPONSORED ADS

$55.6M

1,400,000

3.3%

PRAX PRAXIS PRECISION MEDICINES I

COM NEW

$54.8M

170,000

3.2%

ANAB ANAPTYSBIO INC

COM

$52.1M

940,000

3.1%

— ALKERMES PLC

SHS

$47.7M

1,350,000

2.8%

CYTK CYTOKINETICS INC

COM NEW

$46.2M

700,483

2.7%

ABVX ABIVAX SA

SPONSORED ADS

$45.1M

405,000

2.7%

TEVA TEVA PHARMACEUTICAL INDS LTD

SPONSORED ADS

$42.2M

1,400,000

2.5%

— ARCELLX INC

COMMON STOCK

$41.7M

362,764

2.5%

MRNA MODERNA INC

COM · 认购

$40.6M

800,000

2.4%

NUVL NUVALENT INC

COM

$30.7M

300,000

1.8%

— TERNS PHARMACEUTICALS INC

COM

$29.7M

562,631

1.7%

DNTH DIANTHUS THERAPEUTICS INC

COM

$29.4M

350,000

1.7%

LXEO LEXEO THERAPEUTICS INC

COM

$29.0M

5,050,211

1.7%

COGT COGENT BIOSCIENCES INC

COM

$28.9M

750,000

1.7%

MDGL MADRIGAL PHARMACEUTICALS INC

COM

$28.8M

55,000

1.7%

STRO SUTRO BIOPHARMA INC

COM SHS

$26.6M

1,069,519

1.6%

FBRX FORTE BIOSCIENCES INC

COM NEW

$26.2M

1,011,890

1.5%

ORKA ORUKA THERAPEUTICS INC

COM

$24.5M

499,673

1.4%

TRVI TREVI THERAPEUTICS INC

COM

$23.9M

2,000,172

1.4%

OVID OVID THERAPEUTICS INC

COM

$23.6M

10,636,318

1.4%

ELVN ENLIVEN THERAPEUTICS INC

COM

$23.0M

586,904

1.4%

— ASCENDIS PHARMA A/S

SPONSORED ADR

$21.7M

95,000

1.3%

MLYS MINERALYS THERAPEUTICS INC

COM

$20.3M

750,000

1.2%

AVTX AVALO THERAPEUTICS INC

COM NEW

$20.0M

1,340,840

1.2%

BMY BRISTOL-MYERS SQUIBB CO

COM · 认购

$18.2M

300,000

1.1%

PTGX PROTAGONIST THERAPEUTICS INC

COM

$18.1M

172,125

1.1%

CLDX CELLDEX THERAPEUTICS INC NEW

COM NEW

$15.9M

500,000

0.9%

— ZURA BIO LTD

CLASS A ORD SHS

$15.3M

2,564,303

0.9%

NRIX NURIX THERAPEUTICS INC

COM

$15.0M

967,620

0.9%

SVRA SAVARA INC

COM

$13.7M

2,512,153

0.8%

— OMEROS CORP

NOTE 9.500% 6/1

$13.2M

6,525,000

0.8%

CATX PERSPECTIVE THERAPEUTICS INC

COM NEW

$13.2M

3,164,582

0.8%

— HELIX ACQUISITION CORP III

USD CL A ORD SHS

$12.7M

1,250,000

0.7%

ARWR ARROWHEAD PHARMACEUTICALS IN

COM

$12.5M

200,000

0.7%

DMRA DAMORA THERAPEUTICS INC

COM NEW

$11.7M

450,000

0.7%

EPRX EUPRAXIA PHARMACEUTICALS INC

COM

$11.5M

1,589,005

0.7%

ANRO ALTO NEUROSCIENCE INC

COM SHS

$11.2M

500,000

0.7%

BBIO BRIDGEBIO PHARMA INC

COM

$11.1M

150,000

0.7%

CGEM CULLINAN THERAPEUTICS INC

COM

$11.1M

781,260

0.7%

BLTE BELITE BIO INC

SPONSORED ADS

$10.4M

65,000

0.6%

— WAVE LIFE SCIENCES LTD

SHS

$10.2M

1,401,727

0.6%

VERA VERA THERAPEUTICS INC

CL A

$10.1M

250,000

0.6%

TYRA TYRA BIOSCIENCES INC

COM

$9.9M

257,512

0.6%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

34%前 6 大占比

SPY7.7%APGE6.4%XENE5.7%ERAS5.1%INSM4.6%ROIVANT SCIENCES LTD4.6%